TELCON RF PHARMACEUTICAL. INC. financial statements, including revenue, expenses, profit, and loss

The total revenue of 200230 for the last quarter is 8.83 B KRW, and it's 9.84% higher compared to the previous quarter. The net income of Q2 24 is -9.87 B KRW.